

Frost & Sullivan is pleased to announce that Cellix Bio has been selected as the recipient of the 2020 Indian Drug Discovery Platform Technology Innovation Award
CloseWhat We Do
Revealing the power of AI and humanoid inventiveness to discover new therapeutics
Founded in 2014, we are the leading drug discovery and development company. We generate our own drug design data before combining the critical power of AI with the creativity of involving proprietary platform technology, Synergix AITM and expertise of our world-class scientists. This allows us to shorten the pre-clinical drug discovery stage and, in turn, substantially accelerate the delivery of new treatments to patients worldwide. By reducing the number of compounds analysed, we aim to vividly reduce the time and cost of discovering and developing new medicines. Cellix Bio balances Synergix AITM plus human creativity in the drug discovery.
Our targeted discovery process enables the creation of new markets and solutions to both old and new problems. Driven by the speed and accuracy of our platform, Synergix AITM accomplishes in months what previously took years, saving tens of millions in research and development costs. Each of our lead candidates are unique with powerful therapeutic benefits. The molecular entities that we discover are the first of their kind and patented.
Using our Synergix AITM drug discovery platform and the insights from our successful drug development and clinical data, we can identify synergistic pharmacology between bio-actives, combining them to address disease related biochemical pathways and targets. However the rubrics of drug discovery are very complex - not all are known and some are not readily describable as a restricted set of moves.
Cellix Bio intends to develop targeted therapies
Platform Technologywe have built our firm on eminent science and a profound understanding of the biology behind diseases
Read MoreIntellectual Property300 international patents published, obtained 63 Composition of Matter Issued U.S Patents from the USPTO
Read MorePipelineDrugs with important functional advantages and the capability to deliver both clinical and commercial successes
Read MoreCellix Bio Therapeutic Focused Portfolio
Oncology
Welcome to a better way to Live your Life.
Ophthalmology
Welcome to a better way to Live your Life.
Neurology
Welcome to a better way to Live your Life.
Gastrointestinal
Welcome to a better way to Live your Life.
Anti-Mycotics
Welcome to a better way to Live your Life.
Metabolic Diseases
Welcome to a better way to Live your Life.
Pain and Inflammation
Welcome to a better way to Live your Life.
Dermatology
Welcome to a better way to Live your Life.
Superior in Transformation of Ideas
Building a biopharmaceutical company with selective new technologies, ideas, medicines, and insights leading to superior transformation of ideas; our core competence is to develop and commercialize therapeutic drug products with less development risk and unique benefits for patients within our therapeutic areas of focus
Therapeutic Benefits
Cellix Bio uses it’s proprietary Synergix technology to develop New Molecular Entities with novel chemical structures that target known pathophysiological pathways most likely to yield significant therapeutic benefits.
Strong Scientific Platform Synergix AITM
Using our proprietary technologies and our “Synergix AITM” scientific platform, we are developing new medicines that modulate more than one target in the disease pathway, which potentially improves efficacy and minimizes risk in the discovery and development process.
Team Work
Our team has unique scientific and entrepreneurial experience in the life science industry, including R & D management, formulation development, and business development in renowned biopharmaceutical companies.
